Dr. John N Pritchard, Inspiring Strategies - Qepler Summits And Conferences

Dr. John N Pritchard

Independent Business Owner
Inspiring Strategies
Leicester, United Kingdom

From January 2011 - September 2018, John was CTO for Philips Respironics Drug Delivery, with global accountability for the development of products for the treatment of respiratory diseases. He is now a private consultant specialising in strategic approaches to developing respiratory devices, drugs and digital health.

At different stages in his career across 3 major pharmaceutical companies, he has been associated with the launch of 11 major products and at RDD in April 2018, John received the Charles Thiel award for outstanding research and discovery in respiratory drug delivery.

John has published widely in the field, as well as having served as Board member on various scientific and industry bodies. He has sat on a number of Advisory Boards and is currently a member of the UN Committee that makes recommendations on the essential uses of propellants.

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 23 May 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 23 May 2019
CASE STUDY: Re-thinking the opportunities for nebulised drugs.
  • Unmet medical needs in patients that would benefit from nebulised therapy
  • Potential commercial advantages from developing nebulized therapies ahead of the corresponding inhaler
  • Novel nebuliser technologies including the use of electronics to improve patient management
View Details